Cargando…
Enhancer of Polycomb and the Tip60 complex repress hematological tumor initiation by negatively regulating JAK/STAT pathway activity
Myeloproliferative neoplasms (MPNs) are clonal hematopoietic disorders that cause excessive production of myeloid cells. Most MPN patients have a point mutation in JAK2 (JAK2(V617F)), which encodes a dominant-active kinase that constitutively triggers JAK/STAT signaling. In Drosophila, this pathway...
Autores principales: | Bailetti, Alessandro A., Negrón-Piñeiro, Lenny J., Dhruva, Vishal, Harsh, Sneh, Lu, Sean, Bosula, Aisha, Bach, Erika A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550037/ https://www.ncbi.nlm.nih.gov/pubmed/31072879 http://dx.doi.org/10.1242/dmm.038679 |
Ejemplares similares
-
Pathogenic Impacts of Dysregulated Polycomb Repressive Complex Function in Hematological Malignancies
por: Kaito, Satoshi, et al.
Publicado: (2020) -
A Genetic Screen Reveals an Unexpected Role for Yorkie Signaling in JAK/STAT-Dependent Hematopoietic Malignancies in Drosophila melanogaster
por: Anderson, Abigail M., et al.
Publicado: (2017) -
TIP60 represses activation of endogenous retroviral elements
por: Rajagopalan, Deepa, et al.
Publicado: (2018) -
A tumor suppressive activity of Drosophila Polycomb genes mediated by JAK/STAT signaling
por: Classen, Anne-Kathrin, et al.
Publicado: (2009) -
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
por: Furqan, Muhammad, et al.
Publicado: (2013)